Establishment Labs Holdings Inc. Stock News

Establishment Labs (NASDAQ:ESTA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.com repo

Establishment Labs (NASDAQ:ESTA) will be releasing its earnings data before the market opens on Monday, March 16th. Analysts expect Establishment Labs to post earnings of ($0.56) per share for the qua

Establishment Labs Holdings Inc (NASDAQ:ESTA) has been given an average rating of “Hold” by the six research firms that are currently covering the firm, MarketBeat reports. One research analyst ha

NEW YORK, March 03, 2020 -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health, initially in the breast.

If you want to know who really controls Establishment Labs Holdings Inc. (NASDAQ:ESTA), then you'll have to look at...

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

NEW YORK, Feb. 25, 2020 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and.

Establishment Labs (NASDAQ:ESTA) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Tuesday, BidAskClub reports. A n

Wall Street brokerages expect Establishment Labs Holdings Inc (NASDAQ:ESTA) to post earnings of ($0.56) per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Establ

In a report released yesterday, Marie Thibault from BTIG initiated coverage with a Buy rating on Establishment Labs Holdings (ESTA) and a price target of

In a report released yesterday, Marie Thibault from BTIG initiated coverage with a Buy rating on Establishment Labs Holdings (ESTA

Establishment Labs (NASDAQ:ESTA) and Ocugen (NASDAQ:OCGN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their divid

Establishment Labs (NASDAQ:ESTA) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports. Separately, Zacks Investme

Avanos Medical (NYSE:AVNS) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of thei

Establishment Labs Holdings Inc. (ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announc